Sietske K. Huber-Rosendahl

Leiden, ZH, Netherlands

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications

Cross-reactive antibody and T-cell responses after influenza virus infection in community-dwelling older adults.

Cross-reactive antibody and T-cell responses after influenza virus infection in community-dwelling older adults.

Journal: Journal of virology
Published: May 12, 2026

Mosaic HIV-1 vaccine and SHIV challenge strain V2 loop sequence identity and protection in primates.

Mosaic HIV-1 vaccine and SHIV challenge strain V2 loop sequence identity and protection in primates.

Journal: NPJ vaccines
Published: April 11, 2024

SARS-CoV-2 binding and neutralizing antibody levels after Ad26.COV2.S vaccination predict durable protection in rhesus macaques.

SARS-CoV-2 binding and neutralizing antibody levels after Ad26.COV2.S vaccination predict durable protection in rhesus macaques.

Journal: Nature communications
Published: February 16, 2021

Ad26.COV2.S protects Syrian hamsters against G614 spike variant SARS-CoV-2 and does not enhance respiratory disease.

Ad26.COV2.S protects Syrian hamsters against G614 spike variant SARS-CoV-2 and does not enhance respiratory disease.

Journal: NPJ vaccines
Published: January 08, 2021

Immunogenicity and efficacy of one and two doses of Ad26.COV2.S COVID vaccine in adult and aged NHP.

Immunogenicity and efficacy of one and two doses of Ad26.COV2.S COVID vaccine in adult and aged NHP.

Journal: The Journal of experimental medicine
Published: December 31, 2020

Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques.

Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques.

Journal: Nature
Published: June 20, 2020

Corrigendum: Bacillus Calmette-Guérin-Induced Trained Immunity Is Not Protective for Experimental Influenza A/Anhui/1/2013 (H7N9) Infection in Mice.

Corrigendum: Bacillus Calmette-Guérin-Induced Trained Immunity Is Not Protective for Experimental Influenza A/Anhui/1/2013 (H7N9) Infection in Mice.

Journal: Frontiers in immunology
Published: October 04, 2018

Immunogenicity of Influenza Vaccines: Evidence for Differential Effect of Secondary Vaccination on Humoral and Cellular Immunity.

Immunogenicity of Influenza Vaccines: Evidence for Differential Effect of Secondary Vaccination on Humoral and Cellular Immunity.

Journal: Frontiers in immunology
Published: August 07, 2018

Bacillus Calmette-Guérin-Induced Trained Immunity Is Not Protective for Experimental Influenza A/Anhui/1/2013 (H7N9) Infection in Mice.

Bacillus Calmette-Guérin-Induced Trained Immunity Is Not Protective for Experimental Influenza A/Anhui/1/2013 (H7N9) Infection in Mice.

Journal: Frontiers in immunology
Published: January 22, 2018

Whole-Inactivated Influenza Virus Is a Potent Adjuvant for Influenza Peptides Containing CD8+ T Cell Epitopes.

Whole-Inactivated Influenza Virus Is a Potent Adjuvant for Influenza Peptides Containing CD8+ T Cell Epitopes.

Journal: Frontiers in immunology
Published: January 09, 2018

Chemical Modification of Influenza CD8+ T-Cell Epitopes Enhances Their Immunogenicity Regardless of Immunodominance.

Chemical Modification of Influenza CD8+ T-Cell Epitopes Enhances Their Immunogenicity Regardless of Immunodominance.

Journal: PloS one
Published: February 09, 2016

Synthetic Long Peptide Influenza Vaccine Containing Conserved T and B Cell Epitopes Reduces Viral Load in Lungs of Mice and Ferrets.

Synthetic Long Peptide Influenza Vaccine Containing Conserved T and B Cell Epitopes Reduces Viral Load in Lungs of Mice and Ferrets.

Journal: PloS one
Published: February 19, 2015
Showing 1-12 of 14

Last Updated: 09/26/2026